XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://xconomy.com/boston/2019/08/30/patent-challenge-to-alexion-proceeds-but-no-amgen-biosimilar-yet/60%Monthly2019-08-30 20:15
https://xconomy.com/seattle/2019/08/30/robocalls-crowd-out-real-business-calls-this-startup-has-an-answer/60%Monthly2019-08-30 05:25
https://xconomy.com/national/2019/08/30/bio-roundup-cholesterol-check-jjs-opioid-hit-abbvies-flop-more/60%Monthly2019-08-30 10:54
https://xconomy.com/boston/2019/08/30/boston-tech-watch-draftkings-drives-the-engine-revs-nutonomy-swaps/60%Monthly2019-08-30 16:34
https://xconomy.com/detroit-ann-arbor/2019/08/29/5-8b-for-nothing-abbvie-shelves-stemcentryx-drug-after-latest-flop/60%Monthly2019-08-29 16:16
https://xconomy.com/seattle/2019/08/28/ring-confirms-report-revealing-firm-works-with-400-police-agencies/60%Monthly2019-08-28 23:30
https://xconomy.com/boston/2019/08/28/scholar-rock-cfo-rhonda-chicko-to-leave-in-september/60%Monthly2019-08-28 21:36
https://xconomy.com/new-york/2019/08/28/azitra-appoints-mark-sampson-chief-scientific-officer/60%Monthly2019-08-28 15:32
https://xconomy.com/san-francisco/2019/08/28/ex-nektar-exec-maninder-hora-joins-amunix-pharmaceuticals-c-suite/60%Monthly2019-08-28 15:25
https://xconomy.com/new-york/2019/08/28/celgene-adds-cell-therapies-from-immatics-with-bristol-sale-in-sight/60%Monthly2019-08-28 12:07
https://xconomy.com/san-francisco/2019/08/28/thoughtspot-nabs-248m-for-accessible-analytics-nears-2b-valuation/60%Monthly2019-08-28 19:12
https://xconomy.com/san-diego/2019/08/27/ionis-gets-25m-from-gsk-for-experimental-hepatitis-b-program/60%Monthly2019-08-28 21:38
https://xconomy.com/boston/2019/08/27/nutonomy-taps-chrysler-pacifica-to-get-more-elbow-room-in-self-driving-cars/60%Monthly2019-08-28 13:40
https://xconomy.com/seattle/2019/08/27/seattle-startup-funding-tidbits-blokable-zenoti-pto-exchange/60%Monthly2019-08-27 20:30
https://xconomy.com/boston/2019/08/27/sesen-bios-richard-fitzgerald-to-depart-monica-forbes-is-named-cfo/60%Monthly2019-08-27 15:42
https://xconomy.com/boston/2019/08/27/current-trends-in-translational-oncology/60%Monthly2019-08-27 15:43
https://xconomy.com/seattle/2019/08/27/space-ventures-tom-neary-lands-at-sengine-as-chief-financial-officer/60%Monthly2019-08-27 15:30
https://xconomy.com/san-francisco/2019/08/26/fibrogen-ceo-thomas-neff-passes-away-unexpectedly/60%Monthly2019-08-26 16:43
https://xconomy.com/new-york/2019/08/26/celgene-to-sell-blockbuster-drug-to-amgen-for-13b-to-close-bms-deal/60%Monthly2019-08-26 14:25
https://xconomy.com/san-diego/2019/08/26/for-gw-pharma-ceo-justin-gover-the-cbd-trend-started-20-years-ago/60%Monthly2019-08-27 20:19
https://xconomy.com/national/2019/08/26/new-pcsk9-cholesterol-drug-faces-tough-foe-hint-not-cholesterol/60%Monthly2019-08-28 20:20
https://xconomy.com/seattle/2019/08/23/why-amazons-ascent-spells-bad-news-for-mall-food-courts/60%Monthly2019-08-23 23:02
https://xconomy.com/boston/2019/08/23/vmware-we-bought-carbon-black-for-2-1b-analysts-oh-why/60%Monthly2019-08-29 13:57
https://xconomy.com/national/2019/08/23/gsks-cancer-comeback-continues-with-data-for-multiple-myeloma-drug/60%Monthly2019-08-24 14:18
https://xconomy.com/national/2019/08/23/bio-roundup-sareptas-stumble-opioid-suits-shkrelis-legacy-more/60%Monthly2019-08-24 14:19
https://xconomy.com/boston/2019/08/23/boston-tech-watch-epstein-mit-media-lab-carbon-black-jrni-more/60%Monthly2019-08-24 14:08
https://xconomy.com/national/2019/08/22/new-bc-biotech-chinook-reels-in-65m-to-tackle-kidney-disease/60%Monthly2019-08-23 16:08
https://xconomy.com/boston/2019/08/22/vmware-dropping-4-8b-to-buy-carbon-black-pivotal-software/60%Monthly2019-08-24 14:11
https://xconomy.com/boston/2019/08/22/frequency-therapeutics-names-dana-hilt-chief-medical-officer/60%Monthly2019-08-22 16:41
https://xconomy.com/san-diego/2019/08/22/erasca-promotes-yeung-to-coo-cfo-appoints-chacko-as-new-cbo/60%Monthly2019-08-23 14:38
https://xconomy.com/boston/2019/08/22/cadent-therapeutics-appoints-john-mcbride-cfo/60%Monthly2019-08-22 16:30
https://xconomy.com/san-diego/2019/08/22/retrophin-sinks-as-drug-pharma-bro-martin-shkreli-co-invented-fails/60%Monthly2019-08-23 15:09
https://xconomy.com/boston/2019/08/22/healthcares-future-is-telemedicine-ai-but-will-everyone-benefit/60%Monthly2019-08-21 20:52
https://xconomy.com/san-francisco/2019/08/21/splunk-to-pay-1b-for-saas-app-monitoring-firm-signalfx/60%Monthly2019-08-22 00:18
https://xconomy.com/san-francisco/2019/08/21/fords-autonomic-connects-ev-maker-ayro-to-its-mobility-cloud/60%Monthly2019-08-21 16:06
https://xconomy.com/boston/2019/08/21/uniqure-eliminates-chief-operating-officer-role-mcmillan-to-retire/60%Monthly2019-08-22 15:48
https://xconomy.com/new-york/2019/08/21/amgen-neuro-exec-marek-joins-axsome-as-chief-commercial-officer/60%Monthly2019-08-22 15:51
https://xconomy.com/national/2019/08/21/xcelerate-at-biotech-week-boston-discount-ticket-sale-ends-friday/60%Monthly2019-08-21 13:45
https://xconomy.com/boston/2019/08/21/oncorus-adds-79-5m-to-steer-cancer-fighting-virus-to-human-testing/60%Monthly2019-08-21 12:16
https://xconomy.com/indiana/2019/08/20/elancos-7-6b-deal-with-bayer-bolsters-pets-farm-animals-footprint/60%Monthly2019-08-20 17:35
https://xconomy.com/san-diego/2019/08/20/startup-blooma-launches-with-2-75m-to-digitize-commercial-lending/60%Monthly2019-08-20 18:34
https://xconomy.com/boston/2019/08/19/fda-rejects-sareptas-second-duchenne-drug-citing-safety-concerns/60%Monthly2019-08-20 13:11
https://xconomy.com/seattle/2019/08/19/enterprise-software-startup-ally-nabs-8m-to-support-global-growth/60%Monthly2019-08-19 22:39
https://xconomy.com/san-francisco/2019/08/19/genentechs-sandra-horning-to-retire-levi-garraway-named-successor/60%Monthly2019-08-19 20:32
https://xconomy.com/new-york/2019/08/16/pfizer-spinout-springworks-migraine-drug-firm-satsuma-prep-ipos/60%Monthly2019-08-17 00:49
https://xconomy.com/national/2019/08/16/abbvies-successor-to-humira-wins-fda-ok-for-rheumatoid-arthritis/60%Monthly2019-08-16 22:25
https://xconomy.com/national/2019/08/16/bio-roundup-zolgensma-fallout-duchenne-redux-ebola-boost-more/60%Monthly2019-08-16 06:16
https://xconomy.com/san-francisco/2019/08/16/will-porsche-fans-ever-live-in-a-driverless-world-porsche-says-no/60%Monthly2019-08-16 18:11
https://xconomy.com/boston/2019/08/16/boston-tech-watch-buoy-health-cambridge-crops-polarity-more/60%Monthly2019-08-15 20:08
https://xconomy.com/san-diego/2019/08/15/ups-takes-minority-stake-in-self-driving-truck-startup-tusimple/60%Monthly2019-08-15 22:02
https://xconomy.com/new-york/2019/08/15/springworks-therapeutics-appoints-francis-perier-cfo/60%Monthly2019-08-15 16:57
https://xconomy.com/boston/2019/08/15/motif-unveils-new-name-and-27-5m-to-build-food-ingredients-pipeline/60%Monthly2019-08-15 16:06
https://xconomy.com/national/2019/08/15/four-new-drugs-are-around-the-corner-heres-what-you-need-to-know/60%Monthly2019-08-16 04:18
https://xconomy.com/san-diego/2019/08/14/qualcomm-taps-former-palo-alto-networks-ceo-as-board-chairman/60%Monthly2019-08-14 23:47
https://xconomy.com/national/2019/08/14/after-drought-digital-healths-summer-of-ipos-brings-validation/60%Monthly2019-08-14 19:48
https://xconomy.com/new-york/2019/08/14/ex-acceleron-exec-zeldin-named-immunovant-chief-medical-officer/60%Monthly2019-08-14 19:07
https://xconomy.com/national/2019/08/14/genomics-experts-preview-aug-27-san-francisco-forum/60%Monthly2019-08-14 18:48
https://xconomy.com/boston/2019/08/14/ai-world-conference-and-expo/60%Monthly2019-08-27 15:40
https://xconomy.com/seattle/2019/08/14/mason-raises-25m-to-help-software-firms-deploy-manage-applications/60%Monthly2019-08-14 16:40
https://xconomy.com/wisconsin/2019/08/14/wi-watchlist-amfam-venture-investors-understory-gener8tor-more/60%Monthly2019-08-13 21:56
https://xconomy.com/new-york/2019/08/13/life-science-xchange-the-new-york-breed-of-startups-2/60%Monthly2019-08-13 14:25
https://xconomy.com/boston/2019/08/13/chasing-blueprint-deciphera-plans-fda-filing-for-gi-cancer-drug/60%Monthly2019-08-13 15:48
https://xconomy.com/national/2019/08/12/gsks-us-president-bailey-to-depart-emd-serono-exec-named-successor/60%Monthly2019-08-12 18:42
https://xconomy.com/indiana/2019/08/12/on-target-laboratories-taps-philips-healthcares-barys-for-ceo/60%Monthly2019-08-12 18:36
https://xconomy.com/texas/2019/08/12/orthofix-medical-ceo-mason-to-retire-serbousek-appointed-successor/60%Monthly2019-08-12 16:28
https://xconomy.com/boston/2019/08/12/vor-biopharma-appoints-neons-robert-ang-president-ceo/60%Monthly2019-08-12 16:17
https://xconomy.com/san-diego/2019/08/09/san-diego-tech-roundup-ezoic-trust-will-oska-wellness-more/60%Monthly2019-08-09 21:26
https://xconomy.com/new-york/2019/08/09/melinta-therapeutics-ceo-johnson-resigns-successor-search-underway/60%Monthly2019-08-09 22:23
https://xconomy.com/san-francisco/2019/08/09/cleave-therapeutics-appoints-amy-burroughs-ceo-scott-harris-coo/60%Monthly2019-08-09 22:22
https://xconomy.com/national/2019/08/09/bio-roundup-surprise-news-a-gene-therapy-mess-a-car-t-step/60%Monthly2019-08-09 11:06
https://xconomy.com/boston/2019/08/09/boston-tech-watch-nike-cybereason-care-com-launchbyte-more/60%Monthly2019-08-08 17:54
https://xconomy.com/seattle/2019/08/08/glow-snags-2-3m-to-help-podcasters-connect-to-listeners-make-money/60%Monthly2019-08-09 00:15
https://xconomy.com/boston/2019/08/08/bayer-buys-out-bluerock-betting-at-least-240m-more-on-stem-cell-work/60%Monthly2019-08-08 10:59
https://xconomy.com/san-diego/2019/08/07/organovo-halts-liver-tissue-rd-plans-restructuring-to-cut-costs/60%Monthly2019-08-08 21:36
https://xconomy.com/san-francisco/2019/08/07/assembly-bio-taps-former-gilead-sciences-exec-mchutchison-for-ceo/60%Monthly2019-08-08 18:40
https://xconomy.com/boston/2019/08/07/ribon-therapeutics-taps-sudha-parasuraman-for-chief-medical-officer/60%Monthly2019-08-07 21:18
https://xconomy.com/boston/2019/08/07/rhythm-pharmas-obesity-drug-hits-phase-3-goals-fda-filing-planned/60%Monthly2019-08-07 17:20
https://xconomy.com/wisconsin/2019/08/07/aiq-solutions-hits-on-3-2m-to-pinpoint-drug-resistant-tumors/60%Monthly2019-08-07 17:05
https://xconomy.com/san-diego/2019/08/07/sdsi-accelerator-for-sports-startups-gets-qualcomm-foundation-boost/60%Monthly2019-08-07 15:51
https://xconomy.com/san-francisco/2019/08/07/turning-genomics-into-better-health-on-aug-27-early-bird-rate-ends-soon/60%Monthly2019-08-06 17:31
https://xconomy.com/boston/2019/08/06/womens-health-focused-luca-bio-takes-microbiome-rd-beyond-the-gut/60%Monthly2019-08-06 22:38
https://xconomy.com/boston/2019/08/06/editas-medicine-appoints-cynthia-collins-president-ceo/60%Monthly2019-08-07 22:36
https://xconomy.com/san-francisco/2019/08/06/ex-achaogen-exec-janet-dorling-joins-cymabay-as-chief-commercial-officer/60%Monthly2019-08-07 22:34
https://xconomy.com/national/2019/08/06/fda-despite-manipulated-data-2m-gene-therapy-should-stay-on-market/60%Monthly2019-08-07 00:35
https://xconomy.com/seattle/2019/08/06/seattle-startup-remarkably-gets-4-1m-to-market-real-estate-software/60%Monthly2019-08-06 16:15
https://xconomy.com/boston/2019/08/06/genentechs-hegde-named-foundation-medicine-chief-scientific-officer/60%Monthly2019-08-06 19:30
https://xconomy.com/san-francisco/2019/08/06/allogene-taps-adaptimmunes-rafael-amado-as-chief-medical-officer/60%Monthly2019-08-06 14:25
https://xconomy.com/boston/2019/08/06/inari-reaps-89m-and-eyes-global-farm-market-for-gene-edited-seeds/60%Monthly2019-08-06 02:36
https://xconomy.com/boston/2019/08/06/softbank-commits-200m-to-cybereason-cybersecuritys-newest-unicorn/60%Monthly2019-08-05 19:30
https://xconomy.com/new-york/2019/08/05/dog-toxicity-concerns-extend-fdas-review-of-intra-cellular-neuro-drug/60%Monthly2019-08-05 17:35
https://xconomy.com/boston/2019/08/05/digital-health-gets-real-hear-from-pear-nuance-more-at-x%c2%b7con/60%Monthly2019-08-05 12:57
https://xconomy.com/new-york/2019/08/05/glycomimetics-sickle-cell-drug-flops-as-others-creep-forward/60%Monthly2019-08-05 12:17
https://xconomy.com/san-diego/2019/08/02/acadia-neurocrine-see-stock-price-bump-after-quarterly-earnings/60%Monthly2019-08-02 15:59
https://xconomy.com/national/2019/08/02/bio-roundup-pfizers-future-crispr-in-patients-drug-imports-more/60%Monthly2019-08-02 16:55
https://xconomy.com/boston/2019/08/02/boston-tech-watch-jobble-soofa-dynatrace-markforged-datarobot/60%Monthly2019-08-02 04:05
https://xconomy.com/san-francisco/2019/08/01/adverum-biotechnologies-executive-mehdi-gasmi-to-retire/60%Monthly2019-08-01 22:08
https://xconomy.com/san-francisco/2019/08/01/frontier-medicines-adds-kevin-webster-johannes-hermann-to-c-suite/60%Monthly2019-08-01 21:57
https://xconomy.com/san-diego/2019/08/01/viracta-therapeutics-taps-dan-chevallard-as-chief-financial-officer/60%Monthly2019-08-01 22:00
https://xconomy.com/boston/2019/08/01/bostons-life-science-disruptors-2/60%Monthly2019-08-12 20:54
https://xconomy.com/boston/2019/08/01/dynatrace-shares-jump-marking-first-boston-area-tech-ipo-of-2019/60%Monthly2019-08-01 19:25
https://xconomy.com/indiana/2019/08/01/elanco-boosts-vaccine-portfolio-with-60m-prevtec-acquisition/60%Monthly2019-08-01 16:18
https://xconomy.com/san-francisco/2019/08/01/ford-retreating-from-bold-timeline-buys-quantum-signal-for-av-tech/60%Monthly2019-08-01 16:15
https://xconomy.com/new-york/2019/08/01/amicus-offers-first-look-at-gene-therapy-work-with-battens-data/60%Monthly2019-08-01 12:03